Phase 1 IgG4-Related Diseases Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Inflammatory Myopathy+5 more

China Immunotech (Beijing) Biotechnology Co., Ltd.12 enrolled1 locationNCT06978647

Recruiting

Phase 1

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

ANCA-associated VasculitisIgG4-Related DiseasesLupus Nephritis+1 more

Nanjing University School of Medicine24 enrolled1 locationNCT06285279